vs

Side-by-side financial comparison of Indivior Pharmaceuticals, Inc. (INDV) and VERRA MOBILITY Corp (VRRM). Click either name above to swap in a different company.

Indivior Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($357.0M vs $223.6M, roughly 1.6× VERRA MOBILITY Corp). Indivior Pharmaceuticals, Inc. runs the higher net margin — 28.9% vs 12.0%, a 16.9% gap on every dollar of revenue. VERRA MOBILITY Corp produced more free cash flow last quarter ($9.6M vs $-245.0M).

Indivior is a global specialty pharmaceutical company dedicated to developing and commercializing evidence-based treatments for substance use disorders such as opioid use disorder and alcohol dependence, as well as related mental health conditions. Its primary operating markets are North America and Europe, with a portfolio of approved therapies targeting unmet medical needs for underserved patient groups.

Verra Mobility Corp is a leading global smart mobility technology solution provider. It delivers toll management, parking and traffic compliance enforcement, connected vehicle services, and fleet management tools, serving government transport agencies, rental car operators, commercial fleet owners, and automotive partners across North America, Europe, and Asia-Pacific.

INDV vs VRRM — Head-to-Head

Bigger by revenue
INDV
INDV
1.6× larger
INDV
$357.0M
$223.6M
VRRM
Higher net margin
INDV
INDV
16.9% more per $
INDV
28.9%
12.0%
VRRM
More free cash flow
VRRM
VRRM
$254.6M more FCF
VRRM
$9.6M
$-245.0M
INDV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INDV
INDV
VRRM
VRRM
Revenue
$357.0M
$223.6M
Net Profit
$103.0M
$26.7M
Gross Margin
82.1%
Operating Margin
22.7%
23.2%
Net Margin
28.9%
12.0%
Revenue YoY
0.1%
Net Profit YoY
390.5%
-17.3%
EPS (diluted)
$0.79
$0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDV
INDV
VRRM
VRRM
Q1 26
$223.6M
Q4 25
$357.0M
$257.9M
Q3 25
$314.0M
$261.9M
Q2 25
$302.0M
$236.0M
Q1 25
$266.0M
$223.3M
Q4 24
$221.5M
Q3 24
$307.0M
$225.6M
Q2 24
$299.0M
$222.4M
Net Profit
INDV
INDV
VRRM
VRRM
Q1 26
$26.7M
Q4 25
$103.0M
$18.9M
Q3 25
$42.0M
$46.8M
Q2 25
$18.0M
$38.6M
Q1 25
$47.0M
$32.3M
Q4 24
$-66.7M
Q3 24
$22.0M
$34.7M
Q2 24
$-97.0M
$34.2M
Gross Margin
INDV
INDV
VRRM
VRRM
Q1 26
Q4 25
82.1%
Q3 25
73.2%
Q2 25
82.8%
Q1 25
83.1%
Q4 24
Q3 24
78.5%
Q2 24
73.6%
Operating Margin
INDV
INDV
VRRM
VRRM
Q1 26
23.2%
Q4 25
22.7%
16.7%
Q3 25
13.7%
28.6%
Q2 25
23.8%
26.8%
Q1 25
24.8%
25.7%
Q4 24
-19.6%
Q3 24
11.4%
28.3%
Q2 24
-39.5%
27.5%
Net Margin
INDV
INDV
VRRM
VRRM
Q1 26
12.0%
Q4 25
28.9%
7.3%
Q3 25
13.4%
17.9%
Q2 25
6.0%
16.3%
Q1 25
17.7%
14.5%
Q4 24
-30.1%
Q3 24
7.2%
15.4%
Q2 24
-32.4%
15.4%
EPS (diluted)
INDV
INDV
VRRM
VRRM
Q1 26
$0.17
Q4 25
$0.79
$0.12
Q3 25
$0.33
$0.29
Q2 25
$0.14
$0.24
Q1 25
$0.38
$0.20
Q4 24
$-0.39
Q3 24
$0.16
$0.21
Q2 24
$-0.72
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDV
INDV
VRRM
VRRM
Cash + ST InvestmentsLiquidity on hand
$195.0M
$46.9M
Total DebtLower is stronger
$34.1M
Stockholders' EquityBook value
$-98.0M
$272.0M
Total Assets
$1.2B
$1.7B
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDV
INDV
VRRM
VRRM
Q1 26
$46.9M
Q4 25
$195.0M
$65.3M
Q3 25
$445.0M
$196.1M
Q2 25
$510.0M
$147.7M
Q1 25
$373.0M
$108.5M
Q4 24
$77.6M
Q3 24
$206.1M
Q2 24
$122.0M
Total Debt
INDV
INDV
VRRM
VRRM
Q1 26
$34.1M
Q4 25
$1.0B
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
INDV
INDV
VRRM
VRRM
Q1 26
$272.0M
Q4 25
$-98.0M
$293.0M
Q3 25
$-207.0M
$403.1M
Q2 25
$-257.0M
$352.1M
Q1 25
$-285.0M
$299.6M
Q4 24
$265.1M
Q3 24
$-310.0M
$486.5M
Q2 24
$-281.0M
$438.6M
Total Assets
INDV
INDV
VRRM
VRRM
Q1 26
$1.7B
Q4 25
$1.2B
$1.6B
Q3 25
$1.4B
$1.8B
Q2 25
$1.5B
$1.7B
Q1 25
$1.4B
$1.6B
Q4 24
$1.6B
Q3 24
$1.9B
Q2 24
$1.8B
Debt / Equity
INDV
INDV
VRRM
VRRM
Q1 26
0.13×
Q4 25
3.51×
Q3 25
2.55×
Q2 25
2.93×
Q1 25
3.45×
Q4 24
3.90×
Q3 24
2.13×
Q2 24
2.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDV
INDV
VRRM
VRRM
Operating Cash FlowLast quarter
$-221.0M
$40.8M
Free Cash FlowOCF − Capex
$-245.0M
$9.6M
FCF MarginFCF / Revenue
-68.6%
4.3%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
-2.15×
1.53×
TTM Free Cash FlowTrailing 4 quarters
$-93.0M
$104.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDV
INDV
VRRM
VRRM
Q1 26
$40.8M
Q4 25
$-221.0M
$40.0M
Q3 25
$-39.0M
$77.7M
Q2 25
$158.0M
$75.1M
Q1 25
$75.0M
$63.0M
Q4 24
$40.5M
Q3 24
$2.0M
$108.8M
Q2 24
$88.0M
$40.0M
Free Cash Flow
INDV
INDV
VRRM
VRRM
Q1 26
$9.6M
Q4 25
$-245.0M
$5.7M
Q3 25
$-59.0M
$49.0M
Q2 25
$141.0M
$40.3M
Q1 25
$70.0M
$41.7M
Q4 24
$21.6M
Q3 24
$-5.0M
$85.1M
Q2 24
$84.0M
$26.0M
FCF Margin
INDV
INDV
VRRM
VRRM
Q1 26
4.3%
Q4 25
-68.6%
2.2%
Q3 25
-18.8%
18.7%
Q2 25
46.7%
17.1%
Q1 25
26.3%
18.7%
Q4 24
9.8%
Q3 24
-1.6%
37.7%
Q2 24
28.1%
11.7%
Capex Intensity
INDV
INDV
VRRM
VRRM
Q1 26
Q4 25
6.7%
13.3%
Q3 25
6.4%
11.0%
Q2 25
5.6%
14.8%
Q1 25
1.9%
9.5%
Q4 24
8.5%
Q3 24
2.3%
10.5%
Q2 24
1.3%
6.3%
Cash Conversion
INDV
INDV
VRRM
VRRM
Q1 26
1.53×
Q4 25
-2.15×
2.12×
Q3 25
-0.93×
1.66×
Q2 25
8.78×
1.95×
Q1 25
1.60×
1.95×
Q4 24
Q3 24
0.09×
3.13×
Q2 24
1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INDV
INDV

Sublocade$233.0M65%
Sublingual And Other$69.0M19%
Other$49.0M14%
Perseris$6.0M2%

VRRM
VRRM

Government Solutions segment generated total$105.3M47%
Commercial Services segment generated total$97.8M44%
Parking Solutions segment generated total$20.4M9%

Related Comparisons